Home Cart Sign in  
Chemical Structure| 1334719-95-7 Chemical Structure| 1334719-95-7

Structure of Telacebec
CAS No.: 1334719-95-7

Chemical Structure| 1334719-95-7

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Q203 is an inhibitor of mycobacterium tuberculosis cytochrome bc1, a bacterial enzyme complex needed for respiration.

Synonyms: Q203; IAP6

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Telacebec

CAS No. :1334719-95-7
Formula : C29H28ClF3N4O2
M.W : 557.01
SMILES Code : O=C(C1=C(CC)N=C2C=CC(Cl)=CN21)NCC3=CC=C(N4CCC(C5=CC=C(OC(F)(F)F)C=C5)CC4)C=C3
Synonyms :
Q203; IAP6
MDL No. :MFCD28502122
InChI Key :OJICYBSWSZGRFB-UHFFFAOYSA-N
Pubchem ID :68234908

Safety of Telacebec

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Isoform Comparison

Biological Activity

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT06481163 Buruli Ulcer PHASE2 ACTIVE_NOT_RECRUITING 2025-12-25 Barwon Health, Geelong, Victor... More >>ia, 3220, Australia|Royal Melbourne Hospital, Melbourne, Australia Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.80mL

0.36mL

0.18mL

8.98mL

1.80mL

0.90mL

17.95mL

3.59mL

1.80mL

References

 

Historical Records

Categories